Clinical trials group

What is the importance of clinical trials to our patient?

Clinical trials is priority oncology area, which ensure the emergence of new effective medicines, biomarker research, and justification of medical methodologies by evidence and science. More than 20 phase II, phase III, and phase IV clinical trials, involving approximately 100 patients and 15% of institute staff, are performed in National Cancer Institute every year. Clinical trials of various localizations solid tumors are performed; but the most common are in the areas of breast, prostate, lung, stomach, pancreas and head-neck tumors. Phase I clinical trials will be started in the near future.

Working in the area of clinical trials for more than 15 years, we managed to create the clinical trials coordination structure involving the professional and skilled staff. This allows us to ensure high quality implementation of clinical trials, following the guidelines for good clinical practice. All implemented clinical trials are approved by the Lithuanian Bioethics Committee and the State Medicines Control Agency.

Phase I clinical trials were started in 2019.

Currently, 42 clinical trials are performed in the Institute; 15 of them are actively recruiting patients.

We have the possibility to carry out trials of all phases, from I to IV, in the Institute.